Bookmark
Forward
Explore Literature Results
QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=9C6599398EC860895333FD97B0462613;jsessionid=7CFD220E3A0FB14A78A4716D780E4E0C;jsessionid=49E207B165A11E105CFC9B6E74121F11;jsessionid=4C6D4E4BE3245D2FFE542D7ABEF5A340;jsessionid=F5CB3756DC22680AA058F71B3B3217F1;jsessionid=0E8C6D43C12E71A04C942C5A4E6F7CD1 (gene)
Most Relevant Literature
- Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
- Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
- Stability of varicella-zoster virus open reading frame 63.
- Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
- Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…
Most Relevant Clinical Trials
There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=9C6599398EC860895333FD97B0462613;jsessionid=7CFD220E3A0FB14A78A4716D780E4E0C;jsessionid=49E207B165A11E105CFC9B6E74121F11;jsessionid=4C6D4E4BE3245D2FFE542D7ABEF5A340;jsessionid=F5CB3756DC22680AA058F71B3B3217F1;jsessionid=0E8C6D43C12E71A04C942C5A4E6F7CD1
Explore Clinical Trials Results
